2025 Q3 -tulosraportti
57 päivää sitten41 min
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
3 424
Myynti
Määrä
15 854
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 271 | - | - | ||
| 5 729 | - | - | ||
| 350 | - | - | ||
| 1 000 | - | - | ||
| 19 000 | - | - |
Ylin
0,333VWAP
Alin
0,28VaihtoMäärä
0,4 1 232 148
VWAP
Ylin
0,333Alin
0,28VaihtoMäärä
0,4 1 232 148
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 12.2.2026 |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 23.10. | |
| 2025 Q2 -tulosraportti | 10.7. | |
| 2025 Q1 -tulosraportti | 24.4. | |
| 2024 Q4 -tulosraportti | 22.1. | |
| 2024 Q3 -tulosraportti | 24.10.2024 |
Datan lähde: Quartr, FactSet
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·3 t sittenAnd now for today's foolish AI assessment: Alligator Bioscience Investor Shifts today at 12:26 ∙ News Overview (AI) Alligator Bioscience has announced remarkable shifts in its shareholder base, where two large institutional investors have reported changes in their holdings. Morgan Stanley increased its stake and crossed the 5% ownership threshold, while Avanza Bank Holdings' subsidiary, Avanza Pension, reduced its direct shareholding to below 5%. These transactions, reported on December 15, 2025, indicate significant movements among key investors." We, the living, know that every day in many stocks, very small shifts occur, where a shareholder - often very briefly - goes over or under 5 % with a very small margin. One should normally not pay attention to that - and absolutely not overinterpret, like this: "Alligator Bioscience has announced remarkable shifts in its shareholder base" "REMARKABLE" - GIVE US A BREAK" If Nordnet wants to burden us with AI, then at least have a knowledgeable person review it before it's posted.- ·4 t sitten · MuokattuWe have hardly seen the bottom yet, unless something new comes to the table. 0.20 SEK is unfortunately the realistic price for now - and it can well drop to 0.17 for a period due to the discount to the guarantors. And even further, if the many who hadn't realized it or read the comment section carefully, panic when the price reaches that level, as we see in other biotech stocks right now, where the bottom after the issue has completely fallen out of the stock. It wasn't many days ago that someone paid 0.80 SEK, even though one could have foreseen the expected subsequent (temporary - hopefully) price of around 0.20. But if you don't hold onto your investment, you risk that the price explosion will come when you are out. That's why I like HardBob's comment and his concept "inverted pyramid scheme" so much. "HardBob 17. Nov. It's an inverted pyramid scheme. The longer you're in, the more you lose and the price is diluted to nothing. Sometimes a new issue isn't even completed before the next one is already being planned. Management is blind to this problem that the countless issues create. At least it's not talked about as a problem. At some point, it can turn quickly, and then newly arrived shareholders will stand with a big profit and loyal shareholders with a plaster on their knee." So if you're in the game, you have to hold out and hope - or give up and lose your stake. And then one should probably stay far away from biotech in the future. As can be read in the comment thread, this time too - as always - I have used my usual method for issues in biotech and have continued. The method has been described previously.
·3 päivää sittenYTD is minus 99.9%. World record!
·5 t sitten · MuokattuAnd where do you see a price target of 0.20, who is supposed to have provided that price target? Please send a link.- ·10.12. · MuokattuI don't really want to participate in the issue. But if you don't, you let the underwriters in the issue run away with the value of the products under development for which we have paid the development costs. Therefore, I have sold my holding of the old ordinary share (which is sold at double the price of the new share - and which will drop to 0,20 SEK after the issue) and then use all the money from the sale to participate in the issue. In this way, I support the issue, limit the underwriters' plunder, and have twice as many shares after the issue compared to if I had just kept the ordinary shares. (And at the same time buy additional new shares for 100 % more than I received from the sale. of the ordinary share.) So get on board - unless you just sell everything and run away screaming with the loss. We probably have a long-term belief in this stock, since we once entered it and have participated in the last issues/TO-sales. So it's a shame to just let the underwriters run away with it.
11.12.11.12.Would that be the impact to the original share price? I think the effect was already manifested but the same day the news lifted the share price significantly. Nordnet would also show the current market cap of 264M SEK for the new amount of shares 657M. I would assume that the new stock start trading at that days price. Many would surely sell right away and run with the profits.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q3 -tulosraportti
57 päivää sitten41 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·3 t sittenAnd now for today's foolish AI assessment: Alligator Bioscience Investor Shifts today at 12:26 ∙ News Overview (AI) Alligator Bioscience has announced remarkable shifts in its shareholder base, where two large institutional investors have reported changes in their holdings. Morgan Stanley increased its stake and crossed the 5% ownership threshold, while Avanza Bank Holdings' subsidiary, Avanza Pension, reduced its direct shareholding to below 5%. These transactions, reported on December 15, 2025, indicate significant movements among key investors." We, the living, know that every day in many stocks, very small shifts occur, where a shareholder - often very briefly - goes over or under 5 % with a very small margin. One should normally not pay attention to that - and absolutely not overinterpret, like this: "Alligator Bioscience has announced remarkable shifts in its shareholder base" "REMARKABLE" - GIVE US A BREAK" If Nordnet wants to burden us with AI, then at least have a knowledgeable person review it before it's posted.
- ·4 t sitten · MuokattuWe have hardly seen the bottom yet, unless something new comes to the table. 0.20 SEK is unfortunately the realistic price for now - and it can well drop to 0.17 for a period due to the discount to the guarantors. And even further, if the many who hadn't realized it or read the comment section carefully, panic when the price reaches that level, as we see in other biotech stocks right now, where the bottom after the issue has completely fallen out of the stock. It wasn't many days ago that someone paid 0.80 SEK, even though one could have foreseen the expected subsequent (temporary - hopefully) price of around 0.20. But if you don't hold onto your investment, you risk that the price explosion will come when you are out. That's why I like HardBob's comment and his concept "inverted pyramid scheme" so much. "HardBob 17. Nov. It's an inverted pyramid scheme. The longer you're in, the more you lose and the price is diluted to nothing. Sometimes a new issue isn't even completed before the next one is already being planned. Management is blind to this problem that the countless issues create. At least it's not talked about as a problem. At some point, it can turn quickly, and then newly arrived shareholders will stand with a big profit and loyal shareholders with a plaster on their knee." So if you're in the game, you have to hold out and hope - or give up and lose your stake. And then one should probably stay far away from biotech in the future. As can be read in the comment thread, this time too - as always - I have used my usual method for issues in biotech and have continued. The method has been described previously.
- ·3 päivää sittenYTD is minus 99.9%. World record!·5 t sitten · MuokattuAnd where do you see a price target of 0.20, who is supposed to have provided that price target? Please send a link.
- ·10.12. · MuokattuI don't really want to participate in the issue. But if you don't, you let the underwriters in the issue run away with the value of the products under development for which we have paid the development costs. Therefore, I have sold my holding of the old ordinary share (which is sold at double the price of the new share - and which will drop to 0,20 SEK after the issue) and then use all the money from the sale to participate in the issue. In this way, I support the issue, limit the underwriters' plunder, and have twice as many shares after the issue compared to if I had just kept the ordinary shares. (And at the same time buy additional new shares for 100 % more than I received from the sale. of the ordinary share.) So get on board - unless you just sell everything and run away screaming with the loss. We probably have a long-term belief in this stock, since we once entered it and have participated in the last issues/TO-sales. So it's a shame to just let the underwriters run away with it.11.12.11.12.Would that be the impact to the original share price? I think the effect was already manifested but the same day the news lifted the share price significantly. Nordnet would also show the current market cap of 264M SEK for the new amount of shares 657M. I would assume that the new stock start trading at that days price. Many would surely sell right away and run with the profits.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
3 424
Myynti
Määrä
15 854
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 271 | - | - | ||
| 5 729 | - | - | ||
| 350 | - | - | ||
| 1 000 | - | - | ||
| 19 000 | - | - |
Ylin
0,333VWAP
Alin
0,28VaihtoMäärä
0,4 1 232 148
VWAP
Ylin
0,333Alin
0,28VaihtoMäärä
0,4 1 232 148
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 12.2.2026 |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 23.10. | |
| 2025 Q2 -tulosraportti | 10.7. | |
| 2025 Q1 -tulosraportti | 24.4. | |
| 2024 Q4 -tulosraportti | 22.1. | |
| 2024 Q3 -tulosraportti | 24.10.2024 |
Datan lähde: Quartr, FactSet
2025 Q3 -tulosraportti
57 päivää sitten41 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 12.2.2026 |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 23.10. | |
| 2025 Q2 -tulosraportti | 10.7. | |
| 2025 Q1 -tulosraportti | 24.4. | |
| 2024 Q4 -tulosraportti | 22.1. | |
| 2024 Q3 -tulosraportti | 24.10.2024 |
Datan lähde: Quartr, FactSet
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·3 t sittenAnd now for today's foolish AI assessment: Alligator Bioscience Investor Shifts today at 12:26 ∙ News Overview (AI) Alligator Bioscience has announced remarkable shifts in its shareholder base, where two large institutional investors have reported changes in their holdings. Morgan Stanley increased its stake and crossed the 5% ownership threshold, while Avanza Bank Holdings' subsidiary, Avanza Pension, reduced its direct shareholding to below 5%. These transactions, reported on December 15, 2025, indicate significant movements among key investors." We, the living, know that every day in many stocks, very small shifts occur, where a shareholder - often very briefly - goes over or under 5 % with a very small margin. One should normally not pay attention to that - and absolutely not overinterpret, like this: "Alligator Bioscience has announced remarkable shifts in its shareholder base" "REMARKABLE" - GIVE US A BREAK" If Nordnet wants to burden us with AI, then at least have a knowledgeable person review it before it's posted.
- ·4 t sitten · MuokattuWe have hardly seen the bottom yet, unless something new comes to the table. 0.20 SEK is unfortunately the realistic price for now - and it can well drop to 0.17 for a period due to the discount to the guarantors. And even further, if the many who hadn't realized it or read the comment section carefully, panic when the price reaches that level, as we see in other biotech stocks right now, where the bottom after the issue has completely fallen out of the stock. It wasn't many days ago that someone paid 0.80 SEK, even though one could have foreseen the expected subsequent (temporary - hopefully) price of around 0.20. But if you don't hold onto your investment, you risk that the price explosion will come when you are out. That's why I like HardBob's comment and his concept "inverted pyramid scheme" so much. "HardBob 17. Nov. It's an inverted pyramid scheme. The longer you're in, the more you lose and the price is diluted to nothing. Sometimes a new issue isn't even completed before the next one is already being planned. Management is blind to this problem that the countless issues create. At least it's not talked about as a problem. At some point, it can turn quickly, and then newly arrived shareholders will stand with a big profit and loyal shareholders with a plaster on their knee." So if you're in the game, you have to hold out and hope - or give up and lose your stake. And then one should probably stay far away from biotech in the future. As can be read in the comment thread, this time too - as always - I have used my usual method for issues in biotech and have continued. The method has been described previously.
- ·3 päivää sittenYTD is minus 99.9%. World record!·5 t sitten · MuokattuAnd where do you see a price target of 0.20, who is supposed to have provided that price target? Please send a link.
- ·10.12. · MuokattuI don't really want to participate in the issue. But if you don't, you let the underwriters in the issue run away with the value of the products under development for which we have paid the development costs. Therefore, I have sold my holding of the old ordinary share (which is sold at double the price of the new share - and which will drop to 0,20 SEK after the issue) and then use all the money from the sale to participate in the issue. In this way, I support the issue, limit the underwriters' plunder, and have twice as many shares after the issue compared to if I had just kept the ordinary shares. (And at the same time buy additional new shares for 100 % more than I received from the sale. of the ordinary share.) So get on board - unless you just sell everything and run away screaming with the loss. We probably have a long-term belief in this stock, since we once entered it and have participated in the last issues/TO-sales. So it's a shame to just let the underwriters run away with it.11.12.11.12.Would that be the impact to the original share price? I think the effect was already manifested but the same day the news lifted the share price significantly. Nordnet would also show the current market cap of 264M SEK for the new amount of shares 657M. I would assume that the new stock start trading at that days price. Many would surely sell right away and run with the profits.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
3 424
Myynti
Määrä
15 854
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 271 | - | - | ||
| 5 729 | - | - | ||
| 350 | - | - | ||
| 1 000 | - | - | ||
| 19 000 | - | - |
Ylin
0,333VWAP
Alin
0,28VaihtoMäärä
0,4 1 232 148
VWAP
Ylin
0,333Alin
0,28VaihtoMäärä
0,4 1 232 148
Välittäjätilasto
Dataa ei löytynyt